Clinuvel Pharmaceuticals (DE:UR9)
€4.50-0.08 (-1.75%)
DE:UR9
Clinuvel Pharmaceuticals earnings date
€4.50
At close:-0.08 (-1.75%)
Clinuvel Pharmaceuticals (UR9) Q2 2025 Earnings Report
2 Followers
DE:UR9 Q2 2025 EPS Results
- Actual EPS
- EUR 0.17
- Consensus EPS
- EUR 0.13
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- EUR 0.13
DE:UR9 Q2 2025 Revenue Results
- Actual Revenue
- EUR 22.00M
- Expected Revenue
- EUR 21.42M
- Beat/Miss
- Beat by +EUR 576.33K
- YoY Revenue Growth
- +10.51%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 02/26/2025
- Time
- After Close
- Conference Call
- Wednesday, February 26, 2025
DE:UR9 Upcoming Earnings
Clinuvel Pharmaceuticals 's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:UR9 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UR9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2027 (Q2) | 0.15- | 0.13 | ― | ― |
| Aug 27, 2026 | 2026 (Q4) | 0.310.29 | 0.27 | 7.06% (+0.02) | |
| Feb 25, 2026 | 2026 (Q2) | 0.180.13 | 0.17 | -26.43% (-0.05) | |
| Aug 27, 2025 | 2025 (Q4) | 0.170.27 | 0.3 | -11.13% (-0.03) | |
| Feb 26, 2025 | 2025 (Q2) | 0.130.17 | 0.13 | 32.08% (+0.04) | |
| Aug 29, 2024 | 2024 (Q4) | 0.270.30 | 0.23 | 30.34% (+0.07) | |
| Feb 21, 2024 | 2024 (Q2) | 0.160.13 | 0.14 | -3.64% (-0.00) | |
| Aug 29, 2023 | 2023 (Q4) | 0.230.23 | 0.19 | 24.67% (+0.05) | |
| Feb 22, 2023 | 2023 (Q2) | 0.190.14 | 0.07 | 92.98% (+0.07) | |
| Aug 30, 2022 | 2022 (Q4) | 0.270.19 | 0.22 | -14.85% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


